Fellowship ​

The Australian Academy of Health and Medical Sciences elects the best and brightest minds in the field of medical and health sciences as Fellows.

Fellows are elected in recognition of their outstanding achievements and exceptional contributions to the sector. The Fellowship are acknowledged for their clinical, non-clinical, leadership, industry and research contributions.

Find Fellows of the AAHMS

To find Fellows of our Academy either use the search form below or download the full list of current Fellows here.

About Fellowship with AAHMS






Winthrop Professor
Telethon Kids Institute, University of Western Australia

Prof Susan Prescott is founding President of the Developmental Origins and Health and Disease (‘DOHaD’) Society of ANZ, dedicated to providing strong evidence, education and advocacy around the importance of ‘healthy start to life’. She is internationally recognised for her research in allergy and early immune development, and works at the highest international level of this field. She is the founding Chair and leader of the International Inflammation Network ‘in–‐‑LAME’ focused on promoting early immune health in reducing the risk of many chronic inflammatory diseases in the modern world. As well as over 230 scientific publications she has published several books for the general public promoting general awareness of these concepts.


Deputy Director
The Florey Institute of Neuroscience and Mental Health

Professor Petrou is a neuroscientist focussed on understanding disease mechanisms in genetic epilepsy. He has made seminal contributions to our understanding of the mechanisms underlying the pathology of genetic epilepsy. His pioneering disease models have identified the pathological changes that precede epilepsy, showing that early treatment is critical for controlling seizures and the attendant quality of life destroying comorbidities. His recent work is the first to show that disease mechanism based therapies can be effective treatments in epilepsy paving the way for future precision therapeutics benefiting millions of patients and their families


Deputy Director and NHMRC Senior Principal Research Fellow
St. Vincent’s Institute of Medical Research

Professor Parker’s international reputation in protein crystallography reflects his astonishing output of more than 100 important protein structures. His pioneering studies of membrane-associated proteins are particularly significant, since such proteins are among the most challenging targets for protein crystallography and also important drug targets. The impact of his work has been amplified greatly through the ways he has used biological understanding and drug discovery to complement the structural information he has provided to collaborators. He has received several prestigious awards including the Ramaciotti Medal for Biomedical Research (2011) and was elected a Fellow of the Australian Academy of Science (2010).


Redmond Barry Distinguished Professor; Head, Vaccine and Immunisation Research Group (VIRGo)
Doherty Institute for Infection and Immunity and Murdoch Children’s Research Institute

Professor Terry Nolan AO is an eminent public health researcher of international standing. His research has been principally in immunisation and clinical trials of new vaccines. He has over 220 publications including 205 in refereed journals and over $40m in grant funding. His research has made pivotal contributions enabling licensure of several vaccines now used worldwide, including HPV vaccine, penta and hexavalent combination paediatric vaccines, meningococcal vaccines (B, ACWY combinations), pandemic inactivated influenza vaccines (H1 and H5), live influenza vaccine, varicella and MMRV vaccines. He is a leader in research policy in Australia, and in the measurement of research impact.


Co‐Head, Division of Cancer and Haematology
The Walter and Eliza Hall Institute of Medical Research

Prof Nick Nicola has made profound and enduring discoveries in the field of the molecular regulation of white blood cells. His early work showed that there were four different hormone-like regulators (colony-stimulating factors, CSFs) of white blood cell production and function, and he led the purification of granulocyte CSF (G-CSF), a protein that is now in routine clinical use to treat more than 20 million cancer patients. His team also cloned three cellular receptors that mediated the actions of the regulators and discovered an important new family of signalling molecules that negatively regulate the actions of CSFs and other regulators.

Executive Director
The George Institute Australia

Professor Neal is an internationally recognised expert in the field of salt reduction. He is also an authority in the design, conduct and analysis of clinical trials evaluating new therapies for people with diabetes, high blood pressure and high cholesterol. His clinical research has influenced the medical management of millions around the world and his work in food policy is changing the way that the food and beverage industry develop their products. Professor Neal has a strong focus on community engagement, is the inventor of the award-winning FoodSwitch smartphone application and appears regularly in the medical and general media.

Former Secretary and Chief Medical Officer
Australian Government Department of Health

Professor Murphy has had more than 30 years of leadership roles in the Australian Public Health system, with two distinct career phases. His initial contribution was as a clinician researcher, during which he directed a busy renal unit, lead his own research group which, inter alia, identified and characterised novel human plasma complement inhibitors, was President of the Nephrology Society and a renowned educator. More recently, he has been the longest serving and most successful CEO in the Victorian Public Health system, leading a high performing service, whilst undertaking national leadership roles in workforce reform, end of life care and informatics.

Director, UQ Genome Innovation Hub; Professorial Research Fellow
Institute for Molecular Bioscience, University of Queensland

Professor Montgomery is an NHMRC Principal Research Fellow and Deputy Coordinator of the Genetics and Computational Biology Department at QIMR Berghofer MRC. He has an outstanding track record and is recognized internationally for his studies in reproductive genetics and gene discovery of complex disease. He leads studies of the genetic contribution to important common diseases including endometriosis and in systems biology. He has published influential papers across a range of disciplines in the life sciences and medicine including papers in New England Journal of Medicine, Nature, Nature Genetics, Lancet, Archives of General Psychiatry, and the American Journal of Human Genetics.

Head, Molecular Parasitology Laboratory; NHMRC Senior Principal Research Fellow
QIMR Berghofer Medical Research Institute

Professor McManus’s research focuses on the global elimination of neglected tropical diseases, notably schistosomiasis, a parasitic worm infection affecting 200 million of the world’s poorest people, and putting a further 800 million at risk. He has decades of transformative-research experience and his multi-disciplined team has developed novel techniques and tools, including vaccines, to eradicate this centuries-old disease, which is responsible for major human suffering and significant economic losses. He is a Senior Scientist/Head of Molecular Parasitology at the QIMR Berghofer, and a NHMRC Senior Principal Research Fellow, who holds professorial positions at The University of Queensland and Griffith University.

Vale Donald McManus, November 2022

Deputy Director
The Bionics Institute of Australia

Prof McDermott has devised, developed, and evaluated numerous commercially successful innovations particularly for cochlear implants and hearing aids. Millions of adults and children with hearing impairment around the world benefit directly from his research through improved sound perception. These and other inventions are disclosed in a number of patents and patent applications. In recognition of this work, Prof McDermott in 2009 was the first winner of the Callier Prize in Communication Disorders, a biennial award from the University of Texas, USA. He is an author of over 100 peer-reviewed journal articles and book chapters, and about 200 further publications.

Our Fellows sit at the heart of everything we do. They represent Australia’s leading minds in health and medical sciences, having been recognised for their clinical, non-clinical, leadership, industry and research contributions.

To be considered for election to the Academy’s Fellowship, a candidate must show exceptional professional achievement in a field related to health and/or medicine.

Fellows contribute to the projects and activities of the Academy and must be willing to be active participants.

Successful Fellowship candidates will have shown:

  • Outstanding leadership in their field.
  • Significant and ongoing involvement with issues of health care, prevention of disease, education, research, and health services policy and delivery.

Candidates for Fellowship should meet the following criteria:

  • National and International recognition for excellence in health and medical science
  • Significant, sustained and ongoing contributions to advance health and medical science in Australia (relative to opportunity)
  • Contribution to the profession through leadership and mentorship
  • Raised public understanding and promoting health and medical science in the broader community

Download criteria for Fellowship

Each year, current Fellows of the Academy are invited to nominate up to four new candidates who meet the criteria and fulfil the required expectations.

To ensure the Academy has a representative and diverse membership, Fellows nominating two new candidates are asked to include only a maximum of one man, and Fellows nominating four new candidates are asked to include only a maximum of two men.

How to make a nomination

Fellows wishing to nominate a candidate for Fellowship should contact the secretariat to confirm candidate eligibility and receive and instructions on how to submit the completed nomination documentation online. 

Fellows wishing to nominate a candidate for a Corresponding Fellowship should contact the secretariat for more information.

Secretariat contact details
Email: [email protected]

Phone: 07 3102 7220

Nomination guidelines for ordinary Fellowship

October 2023
Newly elected Fellows of 2023 are inducted at the Annual Meeting.

18 September 2023- 30 November 2023
Nominations are invited from existing Fellows until the closing date of 30 November.

December 2023
Nominations allocated to Selection Committees.

January – April 2024
Referees’ reports sought.

Early May 2024
Selection Committees meet to consider nominations and provide final recommendations to the Council.

Early-to-mid-July 2024
Council meets to finalise recommendations.

Late July 2024
Full Fellowship invited to comment on recommended new fellows.

August 2024
Election results are shared with proposers and candidates (under embargo).

October 2024
Newly elected Fellows of 2024 inducted at the Annual Meeting.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.